Status:
COMPLETED
Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.
Lead Sponsor:
Kuopio University Hospital
Conditions:
Pain
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Prospective double blind study comparing two remifentanil dosing protocols (0.1 and 0.3 mcg/kg/min) during cardiac surgery. Main outcome measures are postoperative opioid requirements (PCA oxycodone) ...
Eligibility Criteria
Inclusion
- Coronary artery bypass grafting patients
Exclusion
- Psychiatric disorders, sleep apnea, cardiac insufficiency
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00757198
Start Date
September 1 2008
End Date
December 1 2011
Last Update
September 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kuopio University hospital
Kuopio, Finland, 70210